CU-Tech Corporation (KOSDAQ:376290)

Ligand Pharmaceuticals Revenue

CU-Tech had revenue of 51.69B KRW in the quarter ending March 31, 2025, a decrease of -29.21%. This brings the company's revenue in the last twelve months to 262.84B, up 23.54% year-over-year. In the year 2024, CU-Tech had annual revenue of 284.17B with 64.33% growth.

• Revenue (ttm): 262.84B
• Revenue Growth: +23.54%
• P/S Ratio: 0.22
• Revenue / Employee: 6.74B
• Employees: 39
• Market Cap: 58.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	284.17B	111.24B	64.33%
Dec 31, 2023	172.93B	-43.51B	-20.10%
Dec 31, 2022	216.44B	-47.40B	-17.97%
Dec 31, 2021	263.85B	42.15B	19.01%
Dec 31, 2020	221.70B	-100.56B	-31.21%